In vitro experiments revealed that knockdown TYRP1 promoted the expression of HLA-A, B, and C. These findings indicate that inhibition of TYRP1 potentially promote the antigen presentation of MHC class I in tumor cells (Figures 5F, G). The gene discussed is HLA-A; the disease is neoplasm.